These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 26119518

  • 1. Early Medical Treatment of Children and Adolescents With Gender Dysphoria: An Empirical Ethical Study.
    Vrouenraets LJ, Fredriks AM, Hannema SE, Cohen-Kettenis PT, de Vries MC.
    J Adolesc Health; 2015 Oct; 57(4):367-73. PubMed ID: 26119518
    [Abstract] [Full Text] [Related]

  • 2. Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.
    Giovanardi G, Morales P, Mirabella M, Fortunato A, Chianura L, Speranza AM, Lingiardi V.
    J Endocrinol Invest; 2019 Oct; 42(10):1231-1240. PubMed ID: 30953318
    [Abstract] [Full Text] [Related]

  • 3. Perceptions of Sex, Gender, and Puberty Suppression: A Qualitative Analysis of Transgender Youth.
    Vrouenraets LJ, Fredriks AM, Hannema SE, Cohen-Kettenis PT, de Vries MC.
    Arch Sex Behav; 2016 Oct; 45(7):1697-703. PubMed ID: 27251640
    [Abstract] [Full Text] [Related]

  • 4. Treating Transgender Youth: Pushing the Dialogue Forward.
    Vance SR, Rosenthal SM.
    J Adolesc Health; 2015 Oct; 57(4):357-8. PubMed ID: 26403838
    [No Abstract] [Full Text] [Related]

  • 5. Management of juvenile gender dysphoria.
    Hembree WC.
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):559-64. PubMed ID: 24468758
    [Abstract] [Full Text] [Related]

  • 6. To treat or not to treat: puberty suppression in childhood-onset gender dysphoria.
    Costa R, Carmichael P, Colizzi M.
    Nat Rev Urol; 2016 Aug; 13(8):456-62. PubMed ID: 27431339
    [Abstract] [Full Text] [Related]

  • 7. Current management of gender identity disorder in childhood and adolescence: guidelines, barriers and areas of controversy.
    Shumer DE, Spack NP.
    Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):69-73. PubMed ID: 23221495
    [Abstract] [Full Text] [Related]

  • 8. Gender dysphoria in children and adolescents: an overview.
    Skordis N, Kyriakou A, Dror S, Mushailov A, Nicolaides NC.
    Hormones (Athens); 2020 Sep; 19(3):267-276. PubMed ID: 32020566
    [Abstract] [Full Text] [Related]

  • 9. Clinical Follow-up of Two Adolescents Diagnosed with Gender Dysphoria.
    Cesur E, Yüksel Ş, Başar K, Kaptan S.
    Turk Psikiyatri Derg; 2022 Sep; 33(3):214-219. PubMed ID: 36148573
    [Abstract] [Full Text] [Related]

  • 10. [Puberty-delaying hormone therapy in adolescents with gender identity disorder].
    Nakatsuka M.
    Seishin Shinkeigaku Zasshi; 2013 Sep; 115(3):316-22. PubMed ID: 23691819
    [Abstract] [Full Text] [Related]

  • 11. [Beyond NICE: Updated Systematic Review on the Current Evidence of Using Puberty Blocking Pharmacological Agents and Cross-Sex-Hormones in Minors with Gender Dysphoria].
    Zepf FD, König L, Kaiser A, Ligges C, Ligges M, Roessner V, Banaschewski T, Holtmann M.
    Z Kinder Jugendpsychiatr Psychother; 2024 Sep; 52(3):167-187. PubMed ID: 38410090
    [Abstract] [Full Text] [Related]

  • 12. Transgender and Gender Nonconforming Youth.
    Forcier M, Olson J.
    Adolesc Med State Art Rev; 2014 Aug; 25(2):377-97. PubMed ID: 27132320
    [No Abstract] [Full Text] [Related]

  • 13. [Puberty Suppression for Adolescents with Gender Dysphoria A Japanese Perspective].
    Matsumoto Y.
    Seishin Shinkeigaku Zasshi; 2017 Aug; 119(1):42-51. PubMed ID: 30629867
    [Abstract] [Full Text] [Related]

  • 14. GnRHa ('Puberty Blockers') and Cross Sex Hormones for Children and Adolescents: Informed Consent, Personhood and Freedom of Expression.
    Pilgrim D, Entwistle K.
    New Bioeth; 2020 Sep; 26(3):224-237. PubMed ID: 32715988
    [Abstract] [Full Text] [Related]

  • 15. Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.
    Costa R, Dunsford M, Skagerberg E, Holt V, Carmichael P, Colizzi M.
    J Sex Med; 2015 Nov; 12(11):2206-14. PubMed ID: 26556015
    [Abstract] [Full Text] [Related]

  • 16. Hormone treatment of children and adolescents with gender dysphoria: an ethical analysis.
    Abel BS.
    Hastings Cent Rep; 2014 Sep; 44 Suppl 4():S23-7. PubMed ID: 25231782
    [Abstract] [Full Text] [Related]

  • 17. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
    Smith KP, Madison CM, Milne NM.
    Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
    [Abstract] [Full Text] [Related]

  • 18. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons.
    Radix A, Davis AM.
    JAMA; 2017 Oct 17; 318(15):1491-1492. PubMed ID: 28903155
    [No Abstract] [Full Text] [Related]

  • 19. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
    van der Loos MATC, Klink DT, Hannema SE, Bruinsma S, Steensma TD, Kreukels BPC, Cohen-Kettenis PT, de Vries ALC, den Heijer M, Wiepjes CM.
    J Sex Med; 2023 Feb 27; 20(3):398-409. PubMed ID: 36763938
    [Abstract] [Full Text] [Related]

  • 20. Position statement: Gender dysphoria in childhood and adolescence. Working Group on Gender Identity and Sexual Development of the Spanish Society of Endocrinology and Nutrition (GIDSEEN).
    Esteva de Antonio I, Asenjo Araque N, Hurtado Murillo F, Fernández Rodríguez M, Vidal Hagemeijer Á, Moreno-Pérez O, Lucio Pérez MJ, López Siguero JP, Grupo GIDSEEN.
    Endocrinol Nutr; 2015 Oct 27; 62(8):380-3. PubMed ID: 25935352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.